333 related articles for article (PubMed ID: 30868551)
1. Epidemiology and Clinical Manifestations of Immune Thrombocytopenia.
Kohli R; Chaturvedi S
Hamostaseologie; 2019 Aug; 39(3):238-249. PubMed ID: 30868551
[TBL] [Abstract][Full Text] [Related]
2. Immune Thrombocytopenia-A Disease or a Group of Disorders? Where Do We Stand in 2019?
Bakchoul T
Hamostaseologie; 2019 Aug; 39(3):225-226. PubMed ID: 31390662
[No Abstract] [Full Text] [Related]
3. Life-threatening bleeding episodes in primary immune thrombocytopenia: a single-center retrospective study of 169 inpatients.
Tsuda H; Tsuji T; Tsuji M; Yamasaki H
Ann Hematol; 2017 Nov; 96(11):1915-1920. PubMed ID: 28808759
[TBL] [Abstract][Full Text] [Related]
4. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama.
Watts RG
Clin Pediatr (Phila); 2004 Oct; 43(8):691-702. PubMed ID: 15494875
[TBL] [Abstract][Full Text] [Related]
5. Silent bleeding in children and adolescents with immune thrombocytopenia: relation to laboratory parameters and health related quality of life.
Tantawy AA; Elsherif NHK; Kenny MA; Aboulfotouh KA; Hassan AE; Kabil ME
J Thromb Thrombolysis; 2020 Aug; 50(2):258-266. PubMed ID: 31956939
[TBL] [Abstract][Full Text] [Related]
6. [Idiopathic thrombocytopenic purpura in children].
Gebauer E; Vijatov G
Med Pregl; 1998; 51(3-4):127-34. PubMed ID: 9611955
[TBL] [Abstract][Full Text] [Related]
7. Fatigue in children and adolescents with immune thrombocytopenia.
Grace RF; Klaassen RJ; Shimano KA; Lambert MP; Grimes A; Bussel JB; Breakey VR; Pastore YD; Black V; Overholt K; Bhat R; Forbes PW; Neunert C
Br J Haematol; 2020 Oct; 191(1):98-106. PubMed ID: 32501532
[TBL] [Abstract][Full Text] [Related]
8. Bleeding manifestations and management of children with persistent and chronic immune thrombocytopenia: data from the Intercontinental Cooperative ITP Study Group (ICIS).
Neunert CE; Buchanan GR; Imbach P; Bolton-Maggs PH; Bennett CM; Neufeld E; Vesely SK; Adix L; Blanchette VS; Kühne T;
Blood; 2013 May; 121(22):4457-62. PubMed ID: 23550040
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular and bleeding outcomes in a population-based cohort of patients with chronic immune thrombocytopenia.
Adelborg K; Kristensen NR; Nørgaard M; Bahmanyar S; Ghanima W; Kilpatrick K; Frederiksen H; Ekstrand C; Sørensen HT; Fynbo Christiansen C
J Thromb Haemost; 2019 Jun; 17(6):912-924. PubMed ID: 30933417
[TBL] [Abstract][Full Text] [Related]
10. Clinical updates in adult immune thrombocytopenia.
Lambert MP; Gernsheimer TB
Blood; 2017 May; 129(21):2829-2835. PubMed ID: 28416506
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for skin, mucosal, and organ bleeding in adults with primary ITP: a nationwide study in Japan.
Hato T; Shimada N; Kurata Y; Kuwana M; Fujimura K; Kashiwagi H; Takafuta T; Murata M; Tomiyama Y
Blood Adv; 2020 Apr; 4(8):1648-1655. PubMed ID: 32320469
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome following splenectomy for chronic and persistent immune thrombocytopenia (ITP) in adults and children : Splenectomy in ITP.
Ahmed R; Devasia AJ; Viswabandya A; Lakshmi KM; Abraham A; Karl S; Mathai J; Jacob PM; Abraham D; Srivastava A; Mathews V; George B
Ann Hematol; 2016 Sep; 95(9):1429-34. PubMed ID: 27370992
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulatory Second-Line Therapies for Immune Thrombocytopenia.
Lambert MP
Hamostaseologie; 2019 Aug; 39(3):266-271. PubMed ID: 31167247
[TBL] [Abstract][Full Text] [Related]
14. Twenty years experience with treatment of idiopathic thrombocytopenic purpura in a single department: results in 490 cases.
Schiavotto C; Rodeghiero F
Haematologica; 1993; 78(6 Suppl 2):22-8. PubMed ID: 8039754
[TBL] [Abstract][Full Text] [Related]
15. Characteristics and management of primary and other immune thrombocytopenias: Spanish registry study.
Palau J; Sancho E; Herrera M; Sánchez S; Mingot ME; Upegui RI; Rodríguez Salazar MJ; de la Cruz F; Fernández MC; González López TJ; Hernández JJ; Ríos E; López-Fernández MF; García M; Hernández JÁ; Sanz MA
Hematology; 2017 Sep; 22(8):484-492. PubMed ID: 28415913
[TBL] [Abstract][Full Text] [Related]
16. [Epidemiology, disease presentation and course of idiopathic thrombocytopenic purpura in Danish children from 1998-2000].
Kjaersgaard M; Edslev PW; Rosthøj S
Ugeskr Laeger; 2008 May; 170(22):1922-6. PubMed ID: 18513475
[TBL] [Abstract][Full Text] [Related]
17. Rate of bleeding-related episodes in elderly patients with primary immune thrombocytopenia: a retrospective cohort study.
Li S; Molony JT; Cetin K; Wasser JS; Altomare I
Curr Med Res Opin; 2018 Feb; 34(2):209-216. PubMed ID: 28748715
[TBL] [Abstract][Full Text] [Related]
18. Duration and morbidity of newly diagnosed idiopathic thrombocytopenic purpura in children: A prospective Nordic study of an unselected cohort.
Rosthøj S; Hedlund-Treutiger I; Rajantie J; Zeller B; Jonsson OG; Elinder G; Wesenberg F; Henter JI;
J Pediatr; 2003 Sep; 143(3):302-7. PubMed ID: 14517509
[TBL] [Abstract][Full Text] [Related]
19. [Diagnosis and Therapy of Immune thrombocytopenia].
Matzdorff A; Wörmann B
Dtsch Med Wochenschr; 2018 Aug; 143(15):1076-1081. PubMed ID: 30060276
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics of chronic idiopathic thrombocytopenia in Chinese children.
Wong MS; Chan GC; Ha SY; Lau YL
J Pediatr Hematol Oncol; 2002 Nov; 24(8):648-52. PubMed ID: 12439037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
